Financial burden of patients with post-acute COVID-19 syndrome, 2025, Scheel-Barteit et al

forestglip

Moderator
Staff member
Financial burden of patients with post-acute COVID-19 syndrome

Jennifer Scheel-Barteit, Caroline Floto, Henrike Höpfner, Thomas Kühlein, Bettina Hohberger, Maria Sebastião

[Line breaks added]


Aim
The present study aimed to analyze the financial burden of German patients with Post‐acute COVID‐19 syndrome (PCS) and its predictors exploratively. Information regarding the financial burden of PCS patients and its predictors is of vital importance to identify patients at high risk and address the support needed by this patient group.

Subject and methods
As no established diagnostic process or therapy exists, many PCS patients are dissatisfied with standard health care and engage in out-of-pocket payments (OOPPs) for diagnostics and therapy. This is particularly problematic as they often experience a simultaneous change of employment status and loss of income. In the present cross-sectional study, data on financial burden (changes in employment status, loss of income, OOPPs) were assessed via a self-report online questionnaire.

Results
PCS is a high subjective financial burden for 91.0% of the participants. About 80% of the PCS patients reported high financial losses due to loss of income and high costs due to OOPPs. A wide spectrum of conventional and complementary / alternative diagnostic and therapeutic procedures was reported.

The most frequent type of OOPP diagnostics were vitamin level tests (56.2%), antibody detection (43.8%), and trace element level tests (42.4%). The most frequent type of OOPP therapies were dietary supplements (67.1%), osteopathy (30.1%), physiotherapy / physical therapy (28.2%), relaxation techniques (24.2%), and acupuncture (20.7%).

In regression analyses, change of employment status was predicted by income, type of health care insurance, subjective impairments in day-to-day-life, physician contacts, Post-COVID-Clinic, and contact with a support group. High loss of income was predicted by sex, higher education, change of employment status, income, type of health care insurance, subjective impairments in day-to-day-life, and physician contacts.

High OOPPs were predicted by education, health status pre PCS, subjective impairments in day-to-day-life, physician contacts, contact to alternative / complementary practitioners, and contact to a support group.

Conclusions
PCS patients in Germany suffer from a high financial double burden of loss of income and additional costs due to OOPP diagnostics and therapies. Until effective PCS therapies are implemented in standard care, patients should receive medical information and counseling. Also, the public should be informed regarding non-effective PCS therapies.

Web | PDF | Journal of Public Health | Open Access
 
These problems have several (political) implications:

(1) Medical support and information strategies regarding the PCS patients at particularly high risk of being victim of useless medical services should be improved.

(2) The public should be informed of non-effective PCS therapies.

(3) Therapies for PCS should be further evaluated. Until effective ones are implemented in standard care, patients should receive medical information and counseling from their general practitioner (that there is no effective therapy at present, that their general practitioner supports them with their symptoms, that therapy research is done, that the long-term prognosis is not hopeless (natural course/remission), and that they should be cautious regarding the promises of expensive OOPP therapies).

(4) Care pathways should be optimized (in case of no effective therapy, this means particularly no unnecessary referrals to other specialists beside Post-COVID-Clinics).

(5) Strategies to enable PCS patients to return to work should be implemented, e.g. structural changes like modifications of working hours, working task, and working place/telework (Straßburger et al. 2023; Cutler 2022).
Other than the Post-COVID clinics that themselves are unproven, this seems like a reasonable take.

The even better option would be to create specialist centres that can follow patients long term and aid research.

It’s also a shame that they seemingly gloss over how the default today is the BPS approach. It isn’t just the patients that need education about avoiding ineffective treatments!
 
Back
Top Bottom